Conditions like cardiovascular disease, sleep apnea, non-alcoholic fatty liver disease, or joint disease related to obesity can support a medical necessity argument that may qualify for continued coverage under different benefit categories
Interestingly, GLP-1RAs have been reported to activate the metabolism of brown fat and increase the energy expenditure in rodents through exercise activities independent of the sympathetic nervous system pathway (3)
31 In a trial evaluating semaglutide for weight loss, the incidence of acute pancreatitis was still low (3 of 1,306 participants) despite a higher dose and more significant weight loss, but none of the 655 individuals in the placebo group developed pancreatitis
Meredith Montgomery, MD, is a board-certified pediatrician, a second-year pediatric emergency medicine fellow at Monroe Carell Jr
Caronna E et al